KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial.

J Clin Oncol · 2025-Apr-10 · PMID 39787453

Panel Panel_A提取完成待 EXE 对齐验证

Time to QoL deterioration

FIG 4. Kaplan-Meier curves for patient-reported QoL, showing time to QoL deterioration, defined as ≥10-point decrease from baseline in the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Module C30. Generated from data for the QoL analysis set (n = 437). HR and 95% CI were calculated using the stratified Cox proportional hazards model. HR, hazard ratio; QoL, quality of life.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.87
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-18T20:19:39+00:00